Journal of Medicinal Chemistry p. 9154 - 9170 (2015)
Update date:2022-08-04
Topics:
Hobson, Adrian D.
Harris, Christopher M.
Van Der Kam, Elizabeth L.
Turner, Sean C.
Abibi, Ayome
Aguirre, Ana L.
Bousquet, Peter
Kebede, Tegest
Konopacki, Donald B.
Gintant, Gary
Kim, Youngjae
Larson, Kelly
Maull, John W.
Moore, Nigel S.
Shi, Dan
Shrestha, Anurupa
Tang, Xiubo
Zhang, Peng
Sarris, Kathy K.
S1P5 is one of 5 receptors for sphingosine-1-phosphate and is highly expressed on endothelial cells within the blood-brain barrier, where it maintains barrier integrity in in vitro models (J. Neuroinflamm. 2012, 9, 133). Little more is known about the effects of S1P5 modulation due to the absence of tool molecules with suitable selectivity and drug-like properties. We recently reported that molecule A-971432 (Harris et al., 2010) (29 in this paper) is highly efficacious in reversing lipid accumulation and age-related cognitive decline in rats (Van der Kam, et al., AAIC 2014). Herein we describe the development of a series of selective S1P5 agonists that led to the identification of compound 29, which is highly selective for S1P5 and has excellent plasma and CNS exposure after oral dosing in preclinical species. To further support its suitability for in vivo studies of S1P5 biology, we extensively characterized 29, including confirmation of its selectivity in pharmacodynamic assays of S1P1 and S1P3 function in rats. In addition, we found that 29 improves blood-brain barrier integrity in an in vitro model and reverses age-related cognitive decline in mice. These results suggest that S1P5 agonism is an innovative approach with potential benefit in neurodegenerative disorders involving lipid imbalance and/or compromised blood-brain barrier such as Alzheimer's disease or multiple sclerosis.
View MoreJiangxi Dongbang Pharmaceutical Co., Ltd.
Contact:+86-795-4433603, 4433388
Address:Fengxin Industrial Park, Fengxin County, Jiangxi Province, P.R.C
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
Contact:27-792-602929
Address:SIDNEY MUFAMADI STREET 009949 X44 0700 POLOKWANE,LIMPOPO
Hangzhou Sartort Biopharma Co., Ltd
website:http://www.sartort.com
Contact:86-571-87039693
Address:No. 57, Tech Park Road, Hangzhou, Zhejiang, China
Doi:10.1021/ja01510a047
(1959)Doi:10.1021/ja01340a056
(1932)Doi:10.1016/j.bmc.2010.05.027
(2010)Doi:10.1080/10426500902953953
(2010)Doi:10.1016/j.carres.2010.05.025
(2010)Doi:10.1007/s11172-009-0131-2
(2009)